Published November 7, 2025 | Version v2
Dataset Open

Including Nonrandomized Evidence in Living Systematic Reviews: Lessons learned from the COVID-NMA initiative.

  • 1. ROR icon Université Paris Cité
  • 2. ROR icon Centre de Recherche Épidémiologie et Statistique
  • 3. Cochrane France
  • 4. 4. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • 5. INSERM
  • 6. 3. Cochrane France
  • 7. 5. Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Norway
  • 8. University Medical Center Freiburg
  • 9. 1. Université Paris Cité
  • 10. 6. Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg im Breisgau, Germany
  • 11. 1. Université Paris Cité and Université
  • 12. Université de Paris, Centre of Research in Epidemiology and Statistics (CRESS), Inserm U1153
  • 13. 7. Epistemonikos Foundation, Chile
  • 14. 8. Universidad del Desarrollo, Santiago, Chile
  • 15. 9. Cochrane Response, Cochrane, London, UK
  • 16. University of the Philippines Manila
  • 17. University of Southampton
  • 18. 4. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
  • 19. 10. Cochrane Review Group on Drugs and Alcohol, Rome, Italy.
  • 20. 1. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), F-75004 Paris, France

Files

COVID-NMA -metadata SR COVID-19 vaccines for NRS.csv

Files (457.0 kB)

Name Size Download all
md5:b283dc1d4f6759bfe4acab7811401f2f
418.0 kB Download
md5:d46fa86f1edc365f3928cd83a7ed4d43
39.0 kB Preview Download